Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Fertility Ovulation Devices Market: By Device Type, Fertility Monitors, and Others), By Technology, By End Users, and Region Forecast 2019-2030.
Fertility Ovulation Devices Market size was valued at US$ 736.2 million in 2023 and is projected to grow at a CAGR of 6.4% from 2024-2030. The market for fertility ovulation devices is being pushed by the growing trend of delayed motherhood, rising incidence of infertility, and expanding awareness of reproductive health. Technological developments in tracking devices also contribute to the growth of the market. Market development may be hampered by the high price of sophisticated gadgets and a lack of knowledge in poorer nations are the restraints of this market. Innovative product development, smartphone app integration, and customized fertility treatments offer tremendous possibilities. Increased e-commerce platforms provide prospects for wider exposure as well are the opportunities of the market. Some of the major trends of this market are growing emphasis on health and self-care reflected in current trends, such as the growing popularity of wearable fertility trackers, the rise in consumer desire for discreet and accurate technology, and the move toward natural and holistic methods of fertility management.
The fertility ovulation devices market share is inclusive of several companies such as Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), Sensiia (UK), and Mira Care (US), LHS Technologies among others, are some of the major players operating in the global fertility test.
• Fertility Focus teamed up with the home-based sperm testing business ExSeed Health. Both businesses would work together to offer pregnancy planning options to couples as part of this cooperation.
• Fertility Focus (UK) released OvuSense App v.2, an enhanced version of the app with features including the ability to examine data in three different ways, more options for documenting events than other applications, and improved tracking cycle accuracy.
• In January 2023, Church & Dwight Co., Inc. launched the First Response Ovulation Test with improved accuracy.
• In 2017, Medical Electronic Systems launched the Yo Home Sperm Test in the U.S. to measure the number of motile sperm in samples at home.
• In November 2021, The MediWise Ovulation Tracker with smartphone connection was introduced by MediWise.
By Device Type: Fertility monitors are electronic gadgets that measure physical indicators, such as basal body temperature or hormonal fluctuations to track fertility. They frequently interfere with smartphone applications offering up-to-date information on the menstrual cycle and ovulation window compared to conventional ovulation prediction kits (OPKs), these monitors provide more thorough and ongoing information. Due to their accuracy, simplicity of use, and convenience, tech-savvy customers are favoring them more and more. Wearable technology, such as patches or wristbands, may be incorporated into fertility monitors, making them non-intrusive and discrete. They are a popular option for people looking for a more thorough and trustworthy tracking system because of their capacity to offer customized fertility information.
By Technology: In the fertility ovulation market, wearable devices are cutting-edge instruments that continuously monitor physiological indicators to forecast ovulation. These devices track markers like heart rate, hormone fluctuation, and basal body temperature throughout the day. They are frequently worn as wristbands, patches, and other discrete form. To give users real-time information regarding their window of fertility, they sync with smartphone applications. Compared with more conventional techniques like ovulation kits, wearable technology provides more specific data and is popular due to its accuracy, ease, and non-invasiveness. Knowledge about the technology customers seek automated, continued monitoring to maximize family planning and fertility control is particularly important for them.
By End User: The market for fertility ovulation devices is dominated by individual customers. These are women or couples who track their fertility and employ personal family planning at home with wearable technology, ovulation prediction kits, or fertility monitors. Many customers increasingly rely on these gadgets to track their ovulation cycle and increase their chance of conception as a result of expanding self-care preferences and understanding of reproductive health issues. This market category is the biggest due to the availability of discreet, user-friendly, and reasonably priced technologies that have enabled people to take charge of their fertility without consulting a doctor frequently. This tendency has been further driven by tech integration and online availability.
Study Period
2024-30Base Year
2023CAGR
6.4%Largest Market
North AmericaFastest Growing Market
Asia pacific
The market for fertility ovulation devices is being pushed by the growing trend of delayed motherhood, the rising incidence of infertility, and expanding awareness of reproductive health. Technological development tracking devices also improve usability and accuracy which drives market expansion. The availability of trustworthy ovulation devices is crucial as consumers are looking for family planning alternatives that work.
The market is severely constrained despite its potential for expansion, by the high price of sophisticated reproductive technologies. This cost may put off buyers, especially in underdeveloped areas where accessibility and knowledge are low. Potential users’ adaption of these devices may also be hampered by a dearth of teaching material about fertility management.
The market for fertility ovulation devices has room to grow thanks to creative product development and the incorporation of smartphone applications for improved user experience. Additionally, customized solutions based on specific requirements may be possible. Furthermore, the growth of e-commerce platforms opens doors for wider distribution for customers throughout the globe.
The growing popularity of wearable fertility trackers, which makes it easier for users to monitor their cycles, is one of the current trends in the market for fertility ovulation devices. A need for privacy in fertility control is also reflected in the rise in customer demand for precise and discrete equipment. Additionally, the industry's product development and marketing methods are being impacted by a move towards natural and holistic approaches to conception as well as greater emphasis on well-being and self-care.
Report Benchmarks |
Details |
Report Study Period |
2024-30 |
Market Size in 2023 |
US$ 736.2 million |
Market CAGR |
6.4% |
By Device Type |
|
By Technology |
|
By End User |
|
By Region |
|
The market for fertility ovulation devices is a quickly changing industry, propelled by both shifting consumer habits and technology breakthroughs. The market is growing as a result of increased infertility rates and growing awareness of reproductive health, and demand is also being fueled by the trend of delayed motherhood. According to analysts, the combination of smartphone apps and wearable technologies will improve user experience and fertility tracking accuracy. However, obstacles like expensive devices and low awareness in underdeveloped areas might prevent growth. All things considered, the industry offers a lot of room for innovation and expansion, especially in the development of more widely available and approachable reproductive treatments.
Download Free Sample Report
The global fertility ovulation devices market was valued at US$ 736.2 million in 2023 and is projected to grow at a CAGR of 6.4% during the forecast period (2024-2030).
• Growing consciousness of reproductive health
• Rising rates of infertility
• Growing trend of delayed parenthood
• Developments in tracking device technology
• Growing interest in wearable fertility monitors
• Growing customer need for discrete and precise devices
• Transition to holistic and natural methods for managing fertility
• Combining smartphone apps with fertility devices
Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany), AdvaCare Pharma (US), AVA (Switzerland), Babystart (UK), Valley Electronics (Germany), are the key companies in the market.
1. Executive Summary |
2. Global Fertility Ovulation Devices Market Introduction |
2.1.Global Fertility Ovulation Devices Market - Taxonomy |
2.2.Global Fertility Ovulation Devices Market - Definitions |
2.2.1.Device Type |
2.2.2.Technology |
2.2.3.End Use |
2.2.4.Region |
3. Global Fertility Ovulation Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Fertility Ovulation Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Fertility Ovulation Devices Market By Device Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Ovulation Prediction Kits (OPKs) |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Fertility Monitors |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Fertility Ovulation Devices Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Urine-based Devices |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Saliva-based Devices |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Wearable Devices |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Fertility Ovulation Devices Market By End Use, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Home Care Settings |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Hospitals/Fertility Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Fertility Ovulation Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Fertility Ovulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Device Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Ovulation Prediction Kits (OPKs) |
9.1.2.Fertility Monitors |
9.1.3.Others |
9.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Urine-based Devices |
9.2.2.Saliva-based Devices |
9.2.3.Wearable Devices |
9.3. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Home Care Settings |
9.3.2.Hospitals/Fertility Clinics |
9.3.3.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Fertility Ovulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Ovulation Prediction Kits (OPKs) |
10.1.2.Fertility Monitors |
10.1.3.Others |
10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Urine-based Devices |
10.2.2.Saliva-based Devices |
10.2.3.Wearable Devices |
10.3. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Home Care Settings |
10.3.2.Hospitals/Fertility Clinics |
10.3.3.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Fertility Ovulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Ovulation Prediction Kits (OPKs) |
11.1.2.Fertility Monitors |
11.1.3.Others |
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Urine-based Devices |
11.2.2.Saliva-based Devices |
11.2.3.Wearable Devices |
11.3. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Home Care Settings |
11.3.2.Hospitals/Fertility Clinics |
11.3.3.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Fertility Ovulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Ovulation Prediction Kits (OPKs) |
12.1.2.Fertility Monitors |
12.1.3.Others |
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Urine-based Devices |
12.2.2.Saliva-based Devices |
12.2.3.Wearable Devices |
12.3. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Home Care Settings |
12.3.2.Hospitals/Fertility Clinics |
12.3.3.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Fertility Ovulation Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Device Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Ovulation Prediction Kits (OPKs) |
13.1.2.Fertility Monitors |
13.1.3.Others |
13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Urine-based Devices |
13.2.2.Saliva-based Devices |
13.2.3.Wearable Devices |
13.3. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Home Care Settings |
13.3.2.Hospitals/Fertility Clinics |
13.3.3.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Swiss Precision Diagnostics (Switzerland) |
14.2.2.Church & Dwight (US) |
14.2.3.Prestige Brands Holdings (US) |
14.2.4.bioZhena (US) |
14.2.5.Fairhaven Health (US) |
14.2.6.Fertility Focus (UK) |
14.2.7.Geratherm Medical (Germany) |
14.2.8.Hilin Life Products (US) |
14.2.9.UEBE Medical (Germany) |
14.2.10.AdvaCare Pharma (US) |
14.2.11.AVA (Switzerland) |
14.2.12.Babystart (UK) |
14.2.13.Valley Electronics (Germany) |
14.2.14.Sensiia (UK) |
14.2.15.Mira Care (US) |
14.2.16.LHS Technologies |
15. Research Methodology |
16. Appendix and Abbreviations |